WASHINGTON — WASHINGTON (AP) — AstraZeneca on Friday turned the second main pharmaceutical producer to announce it had agreed to decrease the price of prescribed drugs for Medicaid below a deal struck with the Trump administration that averted its threats of steep tariffs.
President Donald Trump made the announcement within the Oval Workplace with AstraZeneca CEO Pascal Soriot, who mentioned that in robust negotiations to succeed in a deal, Trump and his crew of officers had “actually saved me up at night time.”
Below the settlement, AstraZeneca will cost most-favored-nation pricing to Medicaid, whereas guaranteeing such pricing on newly launched medicine, Trump mentioned. That entails matching the bottom worth supplied in different developed nations.
“For a few years, Individuals have paid the best costs on this planet for prescribed drugs, by far,” Trump mentioned, including that the brand new deal could reduce costs to “the bottom worth wherever on this planet. That’s what we get.”
AstraZeneca’s deal follows the same settlement Pfizer announced late final month. Advocates have typically praised the administration’s efforts to chop drug costs, although some have expressed issues that an excessive amount of onus is being positioned on the producers to decrease prices with out implementing U.S. coverage safeguards to make sure such outcomes.
Each agreements, nonetheless, construct on an executive order Trump signed in Could that set a deadline for drugmakers to electively decrease costs or face new limits on what the federal government can pay. Trump had advised {that a} collection of offers with drug firms would subsequently be coming.
“The tariffs have been a giant cause he got here right here,” Trump mentioned of Soriot.
Cambridge, United Kingdom-based AstraZeneca makes a spread of most cancers therapies. Its merchandise embody the lung most cancers drug Tagrisso; Lynparza, an oral remedy for ovarian most cancers, and Calquence, which treats continual lymphocytic leukemia.
These medicine introduced in a complete of greater than $7.5 billion in U.S. gross sales final yr.
AstraZeneca introduced Thursday that it might spend $4.5 billion on a brand new manufacturing plant close to Charlottesville, Virginia, and its Republican governor, Glenn Youngkin, spoke throughout Friday’s Oval Workplace announcement to cheer groundbreaking on the brand new facility.
The drugmaker mentioned that venture was the centerpiece of $50 billion in investments the corporate plans to make within the U.S. by 2030.
AstraZeneca mentioned it plans to succeed in $80 billion in complete income by then, half of which will likely be generated in the US.
Trump predicted the funding’s may result in 3,600 jobs domestically “simply to start with.”
One of many AstraZeneca medicine was already topic to cost reductions on account of a Medicare negotiating technique applied below President Biden. Nonetheless, Trump insisted that Democrats should not “get credit score” and advised the celebration’s key leaders could strive.
The bulletins got here months after AstraZeneca said it was scrapping plans to increase a vaccine manufacturing plant in its dwelling nation. The corporate blamed a number of components, together with lowered authorities monetary help.
The Trump administration has put up a touchdown web page for its new web site, TrumpRX.gov, the place individuals will be capable of purchase medicine instantly from producers, in keeping with officers. Each Pfizer and AstraZeneca will supply drugs by way of the location, in keeping with the administration.
The web site’s touchdown web page options two very massive photos of Trump and a promise that the location is “Coming Quickly” in January 2026.
It says on the backside of the web page that the location was “Designed in DC by The Nationwide Design Studio,” the brand new authorities web site design hub that Trump created by govt order in August, which is being led by Airbnb co-founder Joe Gebbia.
___
Related Press writers Tom Murphy and Michelle L. Worth contributed to this report.
